SCHEMBL8974676

SCHEMBL8974676

NS(=O)(=O)c1ccc(C2=CC(CO)(CO)C=C2c2ccc(C(F)(F)F)cc2)nc1

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 2/20 0.47
PTGS2 P35354 7/20 0.41
PTGS1 P23219 3/20 0.41
KDM4E B2RXH2 1/20 0.40
GAA P10253 1/20 0.40
ALOX5AP P20292 3/20 0.39
FEN1 P39748 3/20 0.39
CA12 O43570 2/20 0.38
CA1 P00915 2/20 0.38
CA2 P00918 2/20 0.38
MAPT P10636 1/20 0.38
CA9 Q16790 1/20 0.38
GCK P35557 1/20 0.38
GCKR Q14397 1/20 0.38
CYP2C9 P11712 1/20 0.38
PDPK1 O15530 1/20 0.37
CHRNA7 P36544 2/20 0.37
CA7 P43166 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8974863 0.93 KIF11 (0.47) KIF11PTGS2PTGS1ALOX5APFEN1
SCHEMBL8974509 0.90 KIF11 (0.48) KIF11PTGS2PTGS1KDM4EGAA
SCHEMBL8973752 0.89 KIF11 (0.47) KIF11PTGS2PTGS1KDM4EGAA
SCHEMBL8974368 0.89 PTGS2 (0.45) PTGS2PTGS1
SCHEMBL8974701 0.87 PTGS2 (0.45) PTGS2PTGS1CA1CA2CA9
SCHEMBL8973751 0.87 KIF11 (0.52) KIF11PTGS2PTGS1KDM4EGAA
SCHEMBL8973750 0.87 KIF11 (0.62) KIF11PTGS2PTGS1CA12CA1
SCHEMBL8974399 0.85 KIF11 (0.50) KIF11PTGS2PTGS1KDM4EGAA
SCHEMBL8973796 0.85 KIF11 (0.50) KIF11PTGS2PTGS1KDM4EGAA
SCHEMBL8973832 0.84 PTGS2 (0.50) KIF11PTGS2PTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5576339-A Pyridyl substituted cyclopentadienes for the treatment of inflamation HUANG HORNG-CHIH (US) 1996-11-19 US disclosed
WO-1995030656-A1 SUBSTITUTED CYCLOPENTADIENYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1995-11-16 WO disclosed
US-5418254-A Side effect reduction G. D. SEARLE & CO. (US) 1995-05-23 US disclosed